To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1109 | Bpr1k871 |
Novel potent and selective dual FLT3/AURKA inhibitor
More description
|
|
| DCC1107 | bpmetap1-in-15 |
The first potent inhibitor of Burkholderia pseudomallei methionine aminopeptidase
More description
|
|
| DCC1106 | Bph-652 Potassium |
Squalene synthase (SQS) inhibitor, potently inhibiting CrtM
More description
|
|
| DCC1105 | Bph-651 |
Novel CrtM inhibitor
More description
|
|
| DCC1104 | Bph-1218 |
Novel potent SQS inhibitor
More description
|
|
| DCC1103 | Bpc Hydroiodide |
Novel modulator of TTD-PHD histone reader module, binding to the TTD groove, competing with linker binding and promoting open TTD-PHD conformations
More description
|
|
| DCC1102 | Bp2-94 |
Histamine H3 receptor agonist prodrug
More description
|
|
| DCC1101 | Bp13944 |
Novel, Potential Dengue Virus NS2B/NS3 Protease Inhibitor
More description
|
|
| DCC1100 | Bp-1-108 |
Potent and selective STAT5 inhibitor
More description
|
|
| DCC1099 | Bp1.4160 |
Novel and highly potent histamine H3 receptor ligand
More description
|
|
| DCC1098 | Bot-64 |
Novel IKK-2 inhibitor, targeting the Ser177 and/or Ser181 residues in the kinase's activation loop domain.
More description
|
|
| DCC1097 | Bos-6-2-2-6-crbn |
Proteolysis targeting chimeras (PROTAC), acting as a degrader of oncogenic BCR-ABL
More description
|
|
| DCC1096 | Bos-318 |
Novel. highly potent, selective, cell-permeable furin inhibitor, rescuing key features of cystic fibrosis airway disease
More description
|
|
| DCC1095 | Bop-jf549 |
Novel BOP-conjufated fluorescent dual α9β1/α4β1 integrin inhibitor
More description
|
|
| DCC1094 | Bont-in-33 |
Novel potent inhibitor of Botulinum neurotoxin/A light chain (BoNT/A LC)
More description
|
|
| DCC1093 | Bont/a Lc Inhibitor 33 |
Potent Botulinum Neurotoxin A Light-Chain Inhibitor
More description
|
|
| DCC1092 | Bonannione A |
Natural inhibitor of protein tyrosine phosphatase 1B (PTP1B)
More description
|
|
| DCC1091 | Bodipy625 |
Novel fluorogenic dye for Live-Cell Fluorescence Microscopy
More description
|
|
| DCC1090 | Bodipy495 |
Fluorogenic dye for Live-Cell Fluorescence Microscopy
More description
|
|
| DCC1089 | bodilisant |
Novel Fluorescent, Highly Affine Histamine H3 Receptor Ligand
More description
|
|
| DCC1088 | Boc-phe-vinyl Ketone |
Novel covalent substrate-competitive inactivator of AKT kinase
More description
|
|
| DCC1087 | Bo-1978 |
Inhibitor of topoisomerase I/II, inducing DNA cross-linking and significantly suppressing the growth of various NSCLC cell lines with or without mutations in epidermal growth factor receptor (EGFR)
More description
|
|
| DCC1086 | Bntx Maleatel |
Selective delta 1 opioid receptor antagonist
More description
|
|
| DCC1085 | Bnr10s |
Solvatochromic Nile Red Probe with FRET Quencher Reveal Lipid Order Heterogeneity in Living and Apoptotic Cells
More description
|
|
| DCC1084 | Bnm-iv-147 |
Novel CD4 mimic, inhibiting HIV-1 entry into target cells with both significantly higher potency and neutralization breadth than previous congeners, while maintaining high selectivity for the target virus
More description
|
|
| DCC1083 | Bmy-25368 |
Potent long-acting H2-receptor antagonist
More description
|
|
| DCC1082 | Bmv109 |
Novel fluorescent activity-based probe (ABP), being intrinsically dark and only emitting fluorescence after reaction with the target protease, are ideally suited for imaging techniques such as small animal noninvasive fluorescence imaging and live cell fl
More description
|
|
| DCC1081 | Bmsg-sh-3 |
G-quadruplex ligand, decreasing oncogene expression
More description
|
|
| DCC1080 | Bms-986139 |
Novel pan-genotype inhibitor of HCV NS5B polymerase via binding to the primer grip site
More description
|
|
| DCC1079 | Bms-986133 |
Novel γ-secretase modulator
More description
|
|